TrialHuman immunology2010

Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.

Jarrett E Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.